Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
Zacks.com on MSN10h
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
Pfizer (PFE) closed the most recent trading day at $26.91, moving -0.83% from the previous trading session. This change lagged the S&P 500's 0.16% gain on the day. Meanwhile, the Dow experienced a ...
Deep Dive Into Phreesia Stock: Analyst Perspectives (5 Ratings)
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.0, a high ...
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.
Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer
Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...
Moderna stock seesaws as first US bird flu death puts vaccine development in focus
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
Moderna stock on track for 10% weekly gain after US bird flu death
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
CURE: Analyst Estimates Point To Significant Gains In 2025
Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks.